For: | Duverlie G, Wychowski C. Cell culture systems for the hepatitis C virus. World J Gastroenterol 2007; 13(17): 2442-2445 [PMID: 17552027 DOI: 10.3748/wjg.v13.i17.2442] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i17/2442.htm |
Number | Citing Articles |
1 |
M Carrozzo. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Diseases 2008; 14(2): 123 doi: 10.1111/j.1601-0825.2007.01436.x
|
2 |
Mayura M. Desai, Batbayar Tumurbataar, Yueqing Zhang, Lee-Nien Lillian Chan, Jiaren Sun, Teh-sheng Chan. Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice. Transgenic Research 2011; 20(6): 1273 doi: 10.1007/s11248-011-9494-x
|
3 |
Jarrod Bailey. An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 2. Alternative Replacement Methods. Alternatives to Laboratory Animals 2010; 38(6): 471 doi: 10.1177/026119291003800602
|
4 |
Jarrod Bailey. An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee Model. Alternatives to Laboratory Animals 2010; 38(5): 387 doi: 10.1177/026119291003800501
|
5 |
Jarrod Bailey, Katy Taylor. The SCHER Report on Non-human Primate Research —Biased and Deeply Flawed. Alternatives to Laboratory Animals 2009; 37(4): 427 doi: 10.1177/026119290903700412
|
6 |
Duncan R. Smith. iPSCs for Studying Infectious Diseases. 2021; : 1 doi: 10.1016/B978-0-12-823808-0.00008-0
|
7 |
S. Choi, B. Sainz, P. Corcoran, S. Uprichard, H. Jeong. Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 2009; 39(3): 205 doi: 10.1080/00498250802613620
|
8 |
Maria Giovanna Quaranta, Benedetta Mattioli, Stefano Vella. Glances in Immunology of HIV and HCV Infection. Advances in Virology 2012; 2012: 1 doi: 10.1155/2012/434036
|
9 |
Korra Bhanu Teja, Sridivya Bhagavatula, Aishwarya Bhatta, Shilpa J. Tomar. Emerging Human Viral Diseases, Volume II. 2024; : 547 doi: 10.1007/978-981-97-4480-0_20
|
10 |
Shazia Tabassum Hakim, Cayatineto HW. Prospective approaches to target bovine viral diarrhea virus and hepatitis C virus using miRNA-based inhibitors. Journal of Human Virology & Retrovirology 2024; 11(1): 36 doi: 10.15406/jhvrv.2024.11.00278
|
11 |
A. N. Korovina, V. L. Tunitskaya, M. A. Khomutov, A. R. Simonian, A. R. Khomutov, A. V. Ivanov, S. N. Kochetkov. Biogenic polyamines spermine and spermidine activate RNA polymerase and inhibit RNA helicase of hepatitis C virus. Biochemistry (Moscow) 2012; 77(10): 1172 doi: 10.1134/S0006297912100094
|
12 |
Mohammad S. Khuroo, Mohammad Khuroo, Mehnaaz S. Khuroo, Ahmad A. Sofi, Naira S. Khuroo. COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!. Journal of Clinical and Experimental Hepatology 2020; 10(6): 610 doi: 10.1016/j.jceh.2020.06.003
|